May 27, 2017 2:37 PM ET

Healthcare Providers and Services

Company Overview of Ameritox, Ltd.

Company Overview

Ameritox, Ltd. develops pain medication monitoring solutions for behavioral health clinicians in the United States. It offers laboratory services and practice management tools; Rx GuardianCD, a urine drug monitoring solution that helps clinicians to identify potential abuse, misuse, or diversion of patient medication; Rx Guardian INSIGHT Report, which provides physicians with a view of their chronic pain patient’s medication monitoring results; and Rx Guardian results report that provides information available on patient’s pain medication use in easy-to-read format. The company also provides clinical staff training and support, results interpretation and support, contract and payer partnersh...

300 East Lombard Street

Suite 1610

Baltimore, MD 21202

United States

Founded in 1996





Key Executives for Ameritox, Ltd.

Chief Operating Officer
Age: 50
Chief Laboratory Officer and Senior Vice President
Age: 53
Vice President of Intellectual Property & Program Development
Vice President of Public Relations
Vice Chairman and Special Advisor
Compensation as of Fiscal Year 2016.

Ameritox, Ltd. Key Developments

Ameritox Research Shows Wide Variety of Potential Misuse and Abuse of Other Medications and Drugs in Those Prescribed Opioids

Ameritox has released a new clinical research study illustrating an emerging trend within the raging epidemic of prescription opioid misuse and abuse sweeping the country: abuse of non-prescribed opioids, medications used to treat behavioral health conditions, and illicit drugs in those prescribed opioid therapy. Study results revealed tens of thousands of patients being treated with opioid therapy as testing positive for non-prescribed, powerful opioids like oymorphone, non-prescribed benzodiazepines like Xanax and illicit drugs such as cocaine and heroin. Of more than 970,000 urine samples analyzed from patients each prescribed an opioid medication, nearly 17% tested positive for non-prescribed antidepressants and 14% contained non-prescribed benzodiazepines. In additional, almost 12% of the samples tested positive for non-prescribed opiates, 2% for non-prescribed amphetamines, 1.7% for cocaine and 1% for heroin, among other medications and drugs.

Ingenuity Health Expands Reference Database to Help Assess Medication Adherence in Those with Serious Mental Illness

Ingenuity Health, a service of Ameritox Ltd. expanded its comprehensive reference database that helps clinicians assess medication adherence among patients with Serious Mental Illness. Ingenuity Health has developed a method to help assess adherence in patients prescribed the antipsychotic drug lurasidone, marketed under the brand name Latuda®. The reference database provides behavioral health clinicians help in addressing the ongoing problem of medication non-adherence in those with SMI.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1104 Welsh Road Operations LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ameritox, Ltd., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at